Abstract presented at ECCMID 2018 in Madrid, Spain
Astrid van Wessem1, Frédéric Peyrusson1, Guennaëlle Dieppois2, Paul M. Tulkens*1,Francoise Van Bambeke1
- Université catholique de Louvain, Louvain Drug Research Institute, Pharmacologie cellulaire et
moléculaire, Brussels, Belgium, - Debiopharm International, Lausanne, Switzerland